Skip to main content
. 2018 Oct 22;6:111. doi: 10.1186/s40425-018-0424-9

Fig. 3.

Fig. 3

a PFS and b OS in the overall population (N = 50), and c PFS and d OS based on PD-L1 expression on tumor cells (5% cutoff) in evaluable patients (n = 42). NE, not evaluable